Article Text

PDF
Money, money, money

Statistics from Altmetric.com

In 2009, around £73.5million was spent on the lipid-regulating drug ezetimibe in England (plus around another £10million on the combination product simvastatin plus ezetimibe) out of a total primary care prescribing spend of £8.5billion. By comparison, just £10million was spent on the drug in 2004. This increase (mirrored throughout the UK) contrasts with a fall in overall expenditure …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.